KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) EBITDA (2016 - 2025)

Historic EBITDA for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $18.5 million.

  • Staar Surgical's EBITDA rose 22541.36% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$96.8 million, marking a year-over-year decrease of 47653.67%. This contributed to the annual value of -$12.6 million for FY2024, which is 14488.38% down from last year.
  • As of Q3 2025, Staar Surgical's EBITDA stood at $18.5 million, which was up 22541.36% from -$30.0 million recorded in Q2 2025.
  • Staar Surgical's 5-year EBITDA high stood at $18.5 million for Q3 2025, and its period low was -$57.4 million during Q1 2025.
  • Moreover, its 5-year median value for EBITDA was $7.4 million (2021), whereas its average is $1.1 million.
  • Its EBITDA has fluctuated over the past 5 years, first surged by 110938.39% in 2021, then plummeted by 241648.4% in 2025.
  • Staar Surgical's EBITDA (Quarter) stood at $7.4 million in 2021, then crashed by 86.94% to $964000.0 in 2022, then skyrocketed by 979.36% to $10.4 million in 2023, then crashed by 368.24% to -$27.9 million in 2024, then skyrocketed by 166.25% to $18.5 million in 2025.
  • Its last three reported values are $18.5 million in Q3 2025, -$30.0 million for Q2 2025, and -$57.4 million during Q1 2025.